2016
DOI: 10.1080/21645515.2015.1066050
|View full text |Cite
|
Sign up to set email alerts
|

Duality at the gate: Skin dendritic cells as mediators of vaccine immunity and tolerance

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
12
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 10 publications
(12 citation statements)
references
References 144 publications
0
12
0
Order By: Relevance
“…DCs imprint naïve responses to direct the differentiation of CD4 helper T cells into T H 1, T H 2, T H 17, Tfh, Tr1, and Treg (914). Multiple specialized subtypes of DCs that have been identified can be distinguished by surface markers, which have recently been correlated to their unique transcriptome based programs across mice and humans (1521). …”
Section: Introductionmentioning
confidence: 99%
“…DCs imprint naïve responses to direct the differentiation of CD4 helper T cells into T H 1, T H 2, T H 17, Tfh, Tr1, and Treg (914). Multiple specialized subtypes of DCs that have been identified can be distinguished by surface markers, which have recently been correlated to their unique transcriptome based programs across mice and humans (1521). …”
Section: Introductionmentioning
confidence: 99%
“…It remains unknown if and how these cells have evolved conserved mechanisms of maintaining self tolerance. Homeostatic maturation linked to migration from tissues and leading to tolerance [11, 12] has been distinguished from danger signal based licensing leading to adaptive immunity [13]…”
Section: How Are Tolerance and Immunity Simultaneous Achieved?mentioning
confidence: 99%
“…In the steady state 5-7 % have been estimated to navigate to nearest lymph node for antigen presentation to T cells [12] (while under local inflammatory conditions their migratory rate is significantly increased [6, 8]. Transendothelial migration of pre-DCs to non-lymphoid tissues such as skin is mediated by receptor-ligand interactions, such as CCR4-CCL22/CCL17, CCR6-CCL20, CCR2-CCL2, CCR5-CCL5, and CXCR3-CXCL9/CXCL10/CXCL11.…”
Section: Overview Of DC Subsets and Functional Specializationmentioning
confidence: 99%
“…This new and safe strategy has been logically combined with skin vaccination to maximize the efficacy of vaccines and induce protection. The skin is enriched with professional antigen‐presenting dendritic cells (DCs) and has been considered to be an ideal vaccination site to initiate adaptative immune responses and protection when DCs are provided with a proper cue . Skin‐based vaccination to target antigen‐presenting cells (APCs) has been consistently shown to be superior to the conventional intramuscular route and offer dose sparing .…”
Section: Introductionmentioning
confidence: 99%
“…The skin is enriched with professional antigen-presenting dendritic cells (DCs) and has been considered to be an ideal vaccination site to initiate adaptative immune responses and protection when DCs are provided with a proper cue. 13 Skin-based vaccination to target antigen-presenting cells (APCs) has been consistently shown to be superior to the conventional intramuscular route [14][15][16] and offer dose sparing. [17][18][19] In response to these advantages, various technologies are now in use or under development for skin delivery of vaccines.…”
Section: Introductionmentioning
confidence: 99%